In response to DNA damage, p53 becomes acetylated in response to a wide variety of cellular stress signals on multiple lysine residues in its C terminus (Gu and is required for its activation as a transcription factor Roeder, 1997; Liu et al., 1999; Sakaguchi et al., 1998). that regulates cell cycle arrest, senescence, or apoParticularly, it has been reported that transcriptional ptosis. Here, we report that the conserved bromocoactivator histone acetyltransferases (HATs) p300/ domain of the transcriptional coactivator CBP (CREB CBP (CREB binding protein) and p300/CBP-associated binding protein) binds specifically to p53 at the C-terfactor (PCAF) acetylate K373 and K382 (to a lesser exminal acetylated lysine 382. This bromodomain/acetyltent K372 and K381) and K320, respectively. Lysine acetlysine binding is responsible for p53 acetylation-depenylation or deacetylation of p53 has been directly linked dent coactivator recruitment after DNA damage, a step to its ability to regulate cell cycle arrest and apoptosis essential for p53-induced transcriptional activation of eling complexes, including SAGA and SWI/SNF (Agalioti
previously (Barlev et al., 2001 ). Interestingly, we obfunction, we examined possible involvement of the served that p53 acetylation at K382 was dependent bromodomain in acetylation-mediated p53 association upon the degree of the UV exposure (data not shown) with the transcriptional coactivators. Our study, reand detected as early as 2 hr and peaked at 8 hr after ported here, shows that the bromodomain of the coacti-UV-C exposure at 50 J/m 2 ( Figure 2B ). Under the optivator CBP binds specifically to p53 at the C-terminal mized condition, the bromodomain of CBP formed a acetylated K382. This bromodomain-mediated action is stable complex with lysine-acetylated p53 ( Figure 2C ). responsible for p53 recruitment of CBP in vivo upon Mutation of K373 to alanine did not alter K382 acety-DNA damage, a molecular interaction that is crucial for lation, nor did it affect p53 association with the CBP p53-induced transcriptional activation of the cyclinbromodomain. However, a single K382A or double K373A/ dependent kinase inhibitor p21 in cell cycle arrest. We K382A mutation completely abolished the p53/CBP brofurther determined the three-dimensional structure of modomain association ( Figure 2C ), confirming that the the CBP bromodomain in complex with a K382-acet-CBP bromodomain interacts with p53 by recognizing ylated p53 peptide by nuclear magnetic resonance (NMR) the acetylated K382 site in the cell. spectroscopy. Our structural and mutational analyses It is reported that the N-terminal region of p53 interprovide the detailed structural basis for this molecular acts with effector proteins, including Mdm2 and CBP, mechanism of coactivator recruitment that is essential and that stress-induced phosphorylation in the region for p53 transcriptional regulation in DNA damage control. Figure 2D ). These results suggest centration of a p53 peptide containing AcK382, indicatthat lysine acetylation of p53 is not likely dependent ing interactions between the protein and the peptide. upon its N-terminal region interaction with CBP but may This binding is dependent upon K382 acetylation of the be controlled by regulatory events involving the N-terpeptide with a K D of ‫05ف‬ M, as estimated from NMR minal region that precede the C-terminal lysine acetylatitration. None of the p53 peptides showed any signifition after UV-C irradiation. cant binding to the homologous bromodomain from We further examined this CBP/p53 interaction in the PCAF (Jeanmougin et al., 1997) (data not shown). Notacontext of the full-length proteins. In 10.1 cells, the transbly, the p53 AcK373 and AcK382 peptides have the fected p53 formed a stable complex with the endogesame sequence except that the acetylated lysine is in nous CBP upon UV-C treatment, peaking at 8 hr after a different position, underscoring the selective nature the exposure ( Figure 3A ). The N-terminal deletion muof CBP bromodomain/p53 AcK382 recognition. tant of p53, acetylated at K382 with or without UV-C To examine the specificity of CBP bromodomain/p53 irradiation, also associated with the endogenous CBP binding, we performed an in vitro binding assay using ( Figure 3B ). The UV-dependent CBP/p53 association GST-fusion bromodomains and a biotinylated p53 AcK382 was further confirmed in COS-7 cells by coexpressing peptide that was immobilized onto streptavidin-agarose HA-tagged CBP and Flag-tagged p53 ( Figure 3C ). Albeads. Only the CBP bromodomain but not those from though p53 expression was markedly increased upon PCAF or transcriptional intermediary factor 1␤ (TIF1␤, UV treatment, the UV-induced p53 acetylation at K382 also known as KAP-1) (Friedman et al., 1996) formed resulted in an at least 10-fold enhancement of the CBP/ interactions with the p53 peptide ( Figure 1B) To understand functional importance of the bromoby the HAT domain of CBP or p300 in vitro ( Figure 3D ). domain-mediated CBP/p53 association, we investiTo address the question whether p300 also interacts gated p53-induced p21 activation in 10.1 cells using a with the acetylated p53 after UV-C treatment, we examluciferase assay. UV-C treatment of the 10.1 cells transined the endogenous p53 interactions with CBP or p300 fected with p53 resulted in nearly a 7-fold enhancement in NIH/3T3 cells. As expected, the endogenous p53 of p21 luciferase activity ( Figure 4A , lane 2). This p53-formed a stable complex with the endogenous CBP in mediated p21 activation was dropped to a 5-or 2-fold a K382 acetylation-dependent manner, which was effecincrease in the cells transfected with a K373A or a K382A tively blocked by the transfected CBP bromodomain mutant, respectively (lanes 3 and 4), and almost com-( Figure 3E ). However, while p300 also weakly interacted pletely disappeared with a K373A/K382A double mutant with p53, this interaction was not dependent upon lysine (lane 5). Notably, while expression of wild-type or mutant acetylation, nor affected by the transfected CBP bromop53 upon UV-C treatment was enhanced to a similar domain. These data suggest that p53/p300 association level, the degree of p21-elevated expression agrees with likely does not involve a bromodomain-acetyl-lysine inthat of its activation, which is dependent upon p53 acetylation at K382. The ratio of p21 expression level beteraction, which seems consistent with the recent notion with the CBP bromodomain ( Figure 4E, lanes 7-10) .
of bromodomain mutants to a biotinylated p53 AcK382 peptide immobilized onto streptavidin-agarose beads Transfection of the CBP bromodomain alone had an ( Figure 6A ). These residues are grouped according to effect on cell cycle arrest similar to that of the control their mutation effects on the complex formation: (1) point ( Figure 4E, lanes 1 and 6) . Finally, it appears that UV-C mutation of I1120, I1122, Y1125, I1128, or F1177 to alatreatment of 10.1 cells transfected with the wild-type or nine impaired up to ‫%05ف‬ of bromodomain/p53 peptide mutant p53, with or without the CBP bromodomain, did binding; (2) proteins containing a mutation of V1115A, not affect cell population in S or G2/M phase (data not P1123G, N1163A, or V1174A showed an 80% or greater shown). Taken together, our results demonstrate that reduction in the binding; (3) substitution of Y1167 or p53 acetylation at K382 (to a much lesser extent, if any, N1168 to alanine almost abolished the p53 peptide bindat K373) in response to UV irradiation is responsible for ing; (4) because of the relatively weak effect of I1120A p53-induced p21 activation and cell growth arrest and or I1122A mutation, loss of p53 binding by the I1120-that the CBP bromodomain/p53 AcK382 binding is a key G1121-I1122 deletion mutant is likely due to local strucinteraction for p53 acetylation-dependent coactivator tural perturbations caused by the deletion in the ZA recruitment essential for p53 transcriptional activity.
loop. This reasoning may explain an 80% reduction in p53 binding with P1123G ( Figure 6A) ; and (5) (Figure 5D ). Collectively, these specific interacextensive intermolecular interactions observed for these tions confer a selective association between the CBP residues in the structure ( Figure 5C ) and the complebromodomain and p53.
mentary mutational data of the protein ( Figure 6A ). This clear preference for a bulky hydrophobic residue at Specificity of CBP Bromodomain and p53 Recognition AcKϩ1 explains as to why the CBP bromodomain binds To determine functional importance of CBP bromoAcK382 but not AcK373 or AcK320 site in p53, the latter of which contains a Gly or Lys at AcKϩ1. Finally, the domain residues in p53 binding, we examined binding mutational analysis data and few intermolecular NOEs K373, and K382 (to a lesser extent K372 and K381), specific effects of single or combined acetylation of observed for H(AcKϪ2) and K(AcKϪ1) in the NMR specthese lysine residues on p53 activity remain elusive. Our tra suggest that while these residues N-terminal to study presented here provides the structural underAcK382 are functionally important for p53/CBP bromostanding of the molecular mechanism by which p53 domain binding, they are likely structurally dynamic in recruits the coactivator CBP but not p300 upon UVthe complex.
induced DNA damage via an interaction between its acetylated K382 and the bromodomain of CBP.
Discussion
Our study provides several lines of evidence to support that the CBP bromodomain and p53 AcK382 interGrowing evidence from in vivo studies demonstrates action is functionally important for p53 function in rethat stress-induced lysine acetylation of p53 play an sponse to cellular stress. First, our data suggest that important role in p53 stabilization and activation as a the N-terminal region of p53 plays a negative role in transcription factor (Barlev et vations that the single or double mutants of K382 and/ or K373, which abrogates both acetylation and ubiquitnation at these sites, exhibit UV-induced increased stability similar to that of wild-type p53 suggest that this acetylation-induced stability likely results from collaboratively multiple C-terminal residues, i.e., K320, K373, and K382 (to a lesser extent K372 and K381).
Our finding of p53/CBP association via a bromodomain/AcK382 binding also provides new insights into p53 functions in cellular senescence or apoptosis in response to oncogenic transformation or DNA damage. It has been shown that in these processes the tumor suppressor PML controls the targeting of p53 and CBP into the PML nuclear bodies where a p53-PML-CBP complex is formed (Pearson et al., 2000) . The formation of such a trimeric complex, which is required for p53-induced senescence or apoptosis, is dependent upon acetylation at K382 ( 
Sample Preparation and Plasmid Constructs
In Vitro HAT Assay The bromodomain of CBP (residues 1082-1197) was expressed in In vitro HAT acetylation was done using a procedure described Escherichia coli BL21(DE3) cells in the pET15b vector (Novagen).
previously (Lavau et al., 2000) . The purified GST, GST-p53, or GSTIsotope-labeled proteins were prepared from cells grown on a minip53 mutant was incubated with the HAT domain of p300 (residues mal medium containing 15 NH 4 Cl with or without 13 C 6 -glucose in H 2 O 1195-1707) (Upstate Biotech) or CBP (residues 1174-1850) in a or 75% 2 H 2 O. The protein was purified by nickel-IDA affinity chroma-50 mM Tris buffer (pH 8.0) containing 2% glycerol, 0.1 mM EDTA, tography, followed by thrombin cleavage to remove an N-terminal and 1 mM dithiotheritol and acetyl-CoA for 1 hr at 30ЊC. Acetylation poly-His-tag. GST-fusion bromodomains of CBP (residues 1082-of p53 was assessed by Western analysis using p53 AcK382 an-1197), PCAF (residues 712-832), and TIF1␤ (residues 702-812) were tibody. expressed in E. coli in the pGEX4T3 vector (Pharmacia) and purified with a glutathione-sepharose column. NMR spectra of the recombinant CBP, PCAF, and TIF1␤ were acquired to ensure proper protein NMR Spectroscopy NMR samples contained a protein/peptide complex of ‫5.0ف‬ mM in folding. The acetyl-lysine-containing peptides were ordered from BioSynthesis, Inc. (Lewisville, TX). The CBP bromodomain was also 100 mM phosphate buffer (pH 6.5) containing 5 mM perdeuterated DTT and 0. 
